Purpose
A first objective was to provide an overview of advantages and cautions around so-called retrospective clinical studies. A second objective was to provide guidelines for strong studies that can make a valid contribution to the clinical literature, whether these studies are prospective, retrospective, experimental, or observational. Method
Invited commentaries were solicited from statistical and study design experts. Results
The strength of a clinical study does not lie so much with its point in time relative to data generation, as it lies with study design. In fact, quite surprisingly, data collected in the past can be modeled to create a prospective study, if appropriate. One distinctive strength of observational studies—which are sometimes but not always retrospective—is the ability to obtain a large corpus of data from medical databases rapidly, as sometimes warranted by pressing health care policy and practice issues. Conclusion
Retrospective studies, often considered inferior to prospective, randomized, and controlled clinical trials, can have strength and validity often not recognized in the hierarchy of clinical data.from #ENT via xlomafota13 on Inoreader http://ift.tt/1XRErAe
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου